Strides Pharma shares zoom 8% on US FDA approval for Ursodiol tablets

Ursodiol is used for treatment of patients with primary biliary cirrhosis (PBC)

Shares of Strides Pharma Science rose 8.16 per cent to Rs 614.65.on the BSE on Friday after the company received the approval of US health regulator (US FDA) for Ursodiol Tablets used for treatment of patients with primary biliary cirrhosis (PBC). 

PBC is a progressive disease of the liver caused by a buildup of bile within the liver that results in damage to the small bile ducts that drain bile from the liver.

"Strides Pharma Global, Singapore, has received approval for Ursodiol tablets USP in the strengths of 250 mg and 500 mg from the United States Food and Drug Administration (USFDA),"